This finding is in agreement with Voskaridou et al12 who reported that patients with thalassemia major had increased levels of all studied angiogenic cytokines (such as VEGF, basic fibroblast growth factor, angiogenin, angiopoietin) compared with healthy controls. This evidence concerns the gene FGF2 and thalassemia.